Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for progression of chronic kidney disease
ACTRN12605000693628Phase 4Active, not recruiting
- Sponsor
- Launceston General Hospital
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of atorvastatin in chronic kidney disease (CKD), sponsored by Launceston General Hospital. Primary endpoint: Decline in estimated glomerular filtration rate. Started Mar 2001; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12605000693628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000693628.